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Cell adhesion molecules are thought to play an important role in guiding cell
migration and localization in the development of the embryo and in organoge-
nesis. In the immune system, cell adhesion molecules mediate leukocyte-endo-
thelial cell interactions, and in many types of cell interactions, they enhance the
efficiency of specific receptor-mediated processes . The importance of a family
ofthree leukocyte cell adhesion proteins, LFA-1 (lymphocyte function-associated
antigen 1),' Mac-1 (macrophage antigen 1), and p150,95, has recently been
highlighted by the discovery (1-9) of an immunodeficiency disease in which
expression of these molecules on the surface of leukocytes is lacking . Patients
with a deficiency of these three molecules (for brevity, designated the LFA-1
deficiency here) present with recurrent life-threatening infections, and display
profound defects in adhesion-dependent granulocyte, monocyte, and B andT
lymphocyte functions (2, 4-12) .
LFA-1 has been defined both in mice and in humans (13, 14) . The LFA-1
molecule on normal cells is critically involved in mediating adhesive interactions
by T and B lymphocytes, natural killer cells, and granulocytes, and mediates
homotypic lymphocyte adhesion stimulated by phorbol esters (12, 13, 15, 16) .
The LFA-1 molecule contains an aL subunit ofM, 177,000, and a ,Q subunit of
M, 95,000 (14). Its a subunit is identical to that of the related Mac-1 and p150,95
molecules, which have distinct aM andaX subunits (14) .
Leukocytes from LFA-1-deficient patients lack surface expression of both the
aL and ,Q subunits of LFA-1 (3) . To determine whether the aL, a, or both
subunits are defective in patients' cells, we have tested for interspecies subunit
complementation after fusion ofhumanpatient lymphocytes to an LFA-l+ mouse
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T cell line. In parallel, we produced hybrids with normal human T cells. We
show here that human LFA-1 aL and a subunits from normal cells can associate
with mouse LFA-1 subunits to form interspecies hybrid ao complexes. After
fusion of mouse and LFA-1-deficient patients' cells, surface expression of the
patients' aL, but not ,Q subunit could be rescued by interspecies subunit comple-
mentation, demonstrating that the defect in patients' cells is in the ,0 subunit.
Furthermore, we have mapped the gene encoding the ,0 subunit and hence the
putative defect to human chromosome 21 . We have mapped the aL subunit
gene to human chromosome 16 .
Materials and Methods
Cells and Cell Culture. The hypoxanthine/guanine phosphoribosyl transferase
(HGPRT)-negative LFA-1 + mouse BW5147.G.1 .4 thymoma line was maintainedin RPMI-
1640 medium supplemented with 20 MM L-glutamine, 50 AM 2-ME, 50,ug/ml gentamycin,
and 20% FCS (complete medium). PHA blasts were prepared (3) from isolated peripheral
blood mononuclear cellsfrom LFA-1 deficiency patient 1 (7) or her asymptomatic mother.
PHA blasts were used 10 d after the initiation of culture.
MonoclonalAntibodies.
￿
The rat mAbs M7/14 and M 18/2a have previously been shown
(17) to be specific for the mouse LFA-1 aL and g subunits, respectively. The mouse mAbs
TS1/22 and TS1/18 have previously been shown to be specific for the human LFA-I aL
and ,Q subunits, respectively (14). The P3X63 myeloma IgGI was used as control.
Hybridoma culture supernatants were used for immunofluorescent staining, and mAb
purified from culture supernatants or ascites were used for precipitation .
Fusion and Selection of Mouse X Human Hybrids.
￿
Human patient or control PHA blasts
were fused with murine HGPRT-deficient BW5147 cells at a 4:1 ratio with 50% PEG
1600 according to the method of Kontiainen et al. (18). Aftera 2-wk selection in complete
medium plus HAT, hybrid cellswere grown and expanded in complete medium plus HT.
PHA blasts do not grow in medium lacking IL-2, and HGPRT-deficient BW5147 cells do
not grow in HAT medium. After 1 wk of growth in HT medium, hybrids were stained
by indirect immunofluorescence (see below) and selected by flow cytometry for surface
membrane expression of human LFA-1 subunits. The most brightly fluorescing 1 % of
the cells were aseptically sorted out using a Coulter Epics V cell sorter. Sorted cells were
regrown in complete medium, then reanalyzed by flow cytometry, or sorted again for
hybrids positive or negative for human LFA-1 subunit expression.
Indirect Immunofuorescence Flow Cytometry. Indirect immunofluorescent staining of
cells was done by treating the cells with hybridoma culture supernatants specific for the
aL and a subunits of mouse LFA-1, the aL and # subunits of human LFA-1, or control
supernatant as previously described (19). Cells were indirectly stained with affinity-purified
FITC-labeled anti-rat or mouse IgG (Zymed, Burlingame, CA) and analyzed on an Epics
V flow cytometer gated by forward angle light scatter to exclude dead cells. Data from
the analysis of 109 cells are expressed as fluorescence intensity on an arbitrary logarithmic
scale.
Immunoprecipitation and SDS-PAGE. Cells were enzymatically cell-surface radioiodi-
nated by the glucose oxidase/lactoperoxidase method (3). Triton X-100 lysates of "'I-
labelled cells were precleared with mAb coupled to Sepharose CL-4 B (1 mg/ml) or CNBr-
activated, glycine-quenched Sepharose CL-4 B by three sequential rounds of immunopre-
cipitation (3). The precleared lysates were immunoprecipitated with mAb-Sepharose and
subjected to SDS-8% PAGE and autoradiography as previously described (3).
Chromosome Analysis.
￿
The human chromosomal content of each hybrid cell line was
determined after a routine metaphase harvest (20) and karyotyping using two different
banding techniques. ^-5 X 106 cells from each line were harvested for metaphase chro-
mosomes after a 45-min incubation in 0.00625,ug/ml colcemid at 37'C, a 7-min incubation
in 0.075 M KCI at 37°C, and fixation at room temperature in 3:1 methanol/acetic acid.
Slides were prepared from each harvest and stained with quinacrine mustard dihydro-MARLIN ET AL.
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chloride (QM) (21) for identification ofchromosomes by quinacrine-fluorescein Q-banding
(QFQ-banding) and with 33258 Hoechst and actinomycin D (H-ActD) for discrimination
of mouse and human chromosomes (22). After staining with H-Act D, mouse centromeres
fluoresced brightly in comparison to human centromeres. One notable exception to this
staining pattern is the somewhat brighter fluorescence seen in secondary constrictions of
human chromosomes 1 and 16 (22).
Southern Hybridization.
￿
DNA was extracted from cells by the method of Bell et al .
(23) . After digestion with Eco RI, samples were electrophoresed on 1 .0% agarose gels
and Southern blotted (24) to blotting membranes (Zeta-Probe; Bio-Rad Laboratories,
Richmond, CA). The presence of human chromosome 16 was determined by probing
with a cloned human a, globin gene (25). Human chromosome 21 was identified using
DNA sequences from plasmid pPW228C. This plasmid was derived from the WA17
mouse X human hybrid cell, which contains only human chromosome 21 and contains
sequences originating from that chromosome. Cloned insert DNA was isolated from
plasmid DNA, labeled with s2P by nick-translation, and hybridized to Southern blots by
standard procedures (24).
Results
Selection of Human X Mouse Hybrids.
￿
BW5147, a mouse thymoma line ex-
pressing LFA-I (26), was fused with PHA-stimulated T lymphoblasts derived
from either an LFA-1 deficiency patient, or from her asymptomatic, heterozy-
gous mother. After selection in HAT medium, hybrids expressing human al, or
0 subunits were then separately selected by fluorescence-activated cell sorting
with mAb specific for the respective human LFA-1 subunits. The mouse anti-
human LFA-I a and ,8 subunit-specific mAb used here do not crossreact with
murine LFA-1 (see below, Fig. 2, g and h). Similarly, the rat anti-mouse LFA-1
aL and a subunit-specific mAb used here do not crossreact with human LFA-1
(see below; Fig. 2, a and b). 3 wk after cell fusion, only a minor fraction of the
hybrid cell population expressed human LFA-1 subunits as detected by immu-
nofluorescence flow cytometry. Therefore, hybrid cells expressing human LFA-
1 a or ,B subunits were enriched by serial fluorescence-activated cell sorting.
Representative results from the enrichment of the heterozygous mother X
BW5147 (M X BW) hybrids with human aL-specific mAb are shown in Fig. 1 .
The initial sort of the I % most brightly fluorescing cells (Fig. 1 a) produced
populations with at least 10% of the cells positive for surface human LFA-1 aL
(Fig. 1 b). Repeated enrichment by serial sorting (Fig. 1 b-d) resulted in a hybrid
population that contained >90% human LFA-1 aL+ (Fig. If). Hybrids negative
for human LFA-1 subunit expression (Fig. 1 e) were simultaneously selected
during the last sort for comparative karyotyping.
Parallel serial FACS selections of hybrids derived from the patient's or her
mother's cells were done with human LFA-1 aL or ,8 subunit-specific mAb. By
selection with the appropriate mAb, cells expressing the human al, subunit or ,d
subunit, respectively, were isolated from hybrids derived from the mother's cells
(Fig. 2, i and j). These hybrids were designated M X BW,a' and M X BW,O+,
respectively. The hybrid cells expressed only the selected human LFA-1 subunit.
M X BW,a+ hybrids expressed the human aL subunit, but not the human (3
subunit (Fig. 2i). M X BW,a+ hybrids expressed the human ,d subunit, but not
the human aL subunit (Fig. 2j). All hybrids were positive for both the murine
aL and 0 subunits (Fig. 2, cf). Serial selection of patient-derived hybrids also
produced cells positive for the human aL subunit (Fig. 2k). These hybrids were858
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FIGURE 1 .
￿
Representative selection of mouse X human hybrids expressing human LFA-1 by
serial fluorescence-activated cell sorting . Hybrids derived from the mother's cells were stained
by indirect immunofluorescence with mAb specific for thehuman LFA-I aL subunit, andthe
brightest 1% ofthe cells were sorted aseptically, as indicated by thearrow in a . This population
wasexpanded, then serially resorted for cells staining positive for the human al, subunit with
sorting gates as indicated in b, c, and d . During the fourth serial selection (d), both positive (M
X BW,a+) and negative (M X BW,a) populations were isolated, regrown, then indirectly
stained with either anti-human aL mAbor negative control antibody (e andf) .
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FIGURE 2 .
￿
Cell surface expression of humanandmurine LFA-I aL and /3 subunits on hybrid
cells detected by immunofluorescence flow cytometry . Cells were directly stained with mAb
specific for the al, and ft subunits of mouse LFA-1, the aL and (3 subunits of human LFA-I
(solid lines), or with control mAb (dashed line) . M X BW and P X BW designate hybrids
derived from the mother's and patient's cells, respectively . a+, a- , S+ , 0- denote hybrids
selected by sorting for positive or negative expression of human LFA-I a or 0 subunits .
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designated P X BW,a+. Thus, fusion with mouse lymphocytes rescued surface
expression of the human LFA-1 aL subunit from LFA-1-deficient patient lym-
phocytes. However, when patient-derived hybrids were selected with anti-human
,6 subunit mAb, hybrids positive for human 0 subunit expression could not be
isolated. Similar results were obtained in a second independent selection exper-
iment: hybrids expressing the human ,6 subunit could be isolated from hybrids
derived from the mother's cells (75% a+ after one sort), but not the patient's
cells.
Human and Mouse LFA-1 Subunits Coassociate.
￿
The presence of either human
aL or ,Q subunits on the surface of the hybrid cells along with murine aL and #
subunits might be accounted for by either the presence of nonassociated human
subunits, or by the formation of interspecies ao complexes. When LFA-1 is
solubilized with nonionic detergents from human or murine cells, the a and a
subunits remain noncovalently associated and hence are coimmunoprecipitable
(Fig. 3, A and B), as previously described (14, 26). Thus, if the human subunits
were associated with mouse subunits in the hybrid cells, they should coimmuno-
precipitate. Therefore, we solubilized LFA-1 molecules from '251-labeled hybrid
cells and tested for the presence of interspecies a# complexes by immunoprecip-
itation (Fig. 3, C-H). When lysates of M X BW,a' and P X BW,a' hybrids were
immunoprecipitated with an mAb specific for the human LFA-1 aL subunit, a
band comigrating with the mouse ,Q subunit was coprecipitated with the human
aL subunit (Fig. 3, C and E, lane 3 in each). The human aL subunit was of
higher Mr than the mouse aL subunit from the same hybrid cells (compare Fig.
3, C and E, lanes 2 and 3), and resembled human aL from PHA blasts in Mr
(Fig. 3A, lane 3). This human aL subunit was removed when lysates of the
hybrids were precleared with mAb to the mouse ,B subunit (compare Fig. 3C,
lane 3; and D, lane 3). These results provide immunological and biochemical
evidence that these hybrids express authentic human aL subunits, and that these
subunits are associated with murine 0 subunits in a,8 complexes. The results with
P X BW,a' hybrids further suggest that the rescue of surface expression of the
human aL subunit from LFA-1-deficient patient's cells is due to the formation
of an interspecies hybrid complex with the murine 0 subunit.
Similar evidence showed that the M X BW,,Q+ hybrids expressed the human ,B
subunit noncovalently associated with the mouse aL subunit . The anti-human a
mAb coprecipitated the mouse aL subunit and the human a subunit (Fig. 3 G,
lane 4). The human a subunit was of lower Mr than the mouse a subunit
precipitated from the same hybrid cells (Fig. 3G, compare lanes 4 and 2).
Furthermore, preclearing with anti-mouse aL subunit mAb removed most of
the mouse aL subunit precipitable with the anti-human # mAb (Fig. 3, H and
G, compare lane 4 in each) .
Chromosome Mapping ofHuman LFA-1 aL and 0Subunit Genes.
￿
Mouse-human
hybrids generally retain mouse chromosomes, but rapidly lose human chromo-
somes. As described above, only a small percentage of hybrid cells was positive
for human aL or (3 subunits 3 wk after fusion . Furthermore, cell surface
expression of the human aL and /3 subunits on the serially sorted, enriched
hybrid cell populations was not stable, and was lost with repeated passage. We
took advantage of this instability to map the chromosomal locations ofthe human860
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FIGURE 3.
￿
Coassociation of human and murine LFA-1 aL and ,B subunits on the cell surface
ofhybrid cells . Triton X-100 lysates of "5I-labeled mother's PHA blasts, mouse BW5147 cells,
and hybrids were precleared with mAb coupled to Sepharose CL-4 B (1 mg/ml) or CNBr-
activated, glycine-quenched SepharoseCL-4 B(Seph) as a control . The precleared lysateswere
immunoprecipitated with mAb specific for the designated LFA-I subunits, and the immuno-
precipitates were subjected to SDS-8% PAGE and autoradiography . The anti-mouse and
human a and # subunit mAb immunoprecipitated the expected subunits in a species-specific
manner . In addition, a spurious band was immunoprecipitated by the anti-human 0 subunit
mAb from mouseBW5147 cells as well as human 0' anda+ (data notshown) hybrids prepared
from it . This band migrated distinctly from the mouse0subunit in several other experiments,
and wasnot associated with the mouse a subunit . The identity of this protein is not known .
LFA-1 aL and 0 subunit genes . During the last serial selection, both positive and
negative hybrids were isolated for karyotypic analysis . The negative hybrids were
isolated from cells that had been positive during the previous serial selection .
Positive and negative hybrids as well as unfused mouse parental BW5147 cells
were karyotyped after metaphase preparations were stained withQM or with H-
Act D (Fig . 4) . At the time of the karyotypic analyses, ?90% of the cells of
positive hybrid lines expressed the appropriate cell surface human LFA-1 sub-
units, as detected by flow cytometry (Table 1) . Very few human chromosomes
were retained in the hybrids, and the genes encoding the human aL and ,0
subunits could be assigned by comparison of positive hybrids with the negative
hybrids derived from the same population . Expression ofhumanaL was concor-
dant with the presence of human chromosome 16, and therefore the human aLMARLIN ET AL .
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FIGURE 4.
￿
Metaphase chromosome spreads of mouse X human hybrids stained with QM or
H-ActD. A, C, and E are representative metaphase spreads from the positive hybrids M X
BW (3', M X BW,a' and P X BW,a', respectively, stained with QM. B, D, andF are typical
metaphase spreads from M X BW B', M X BW,a', andP X BW,a', respectively, stained with
H-ActD. Human chromosomes 21 and 16 are indicated . In addition, human chromosomes X
and 11 are noted in several of the photographs.
gene can be assigned to this chromosome . -90% of M X BW,a' hybrids and
30% of PX BW,a'hybrids contained human chromosome 16 . These differences
may reflect a faster rate of loss of chromosome 16 from P X BW,a' than M X
BW,a' hybrids and the fact that mRNA and protein on the hybrid cell surface
could remain for some time after chromosome loss . Similarly, the human (3 gene
could be assigned to human chromosome 21 by comparing human (l subunit-
positive hybrids with hybrids that had lost human a subunit expression . The
presence of a human X chromosome in all hybrids was not unexpected, since
this chromosome codes forHGPRT, the enzyme necessary for growth in selective
HAT medium . No other human chromosome was detected in these hybrids
except for the nonconcordant presence of human chromosome 11 in both P X
BW,a' and P X BW,a- cell populations (Table 1) .
The presence ofhumanchromosomes 16 and 21 in human aL+ and 0+ hybrids,862
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Hybrid
positive
cells (°k)*
QM
M X BW,a*
￿
93
￿
33
￿
40
M X BW,a- ￿0
￿
25
￿
25
TABLE I
Chromosome Analysis ofHybrids
Number of
￿
Metaphases (%) with human chromosome:t
metaphases
examined
￿
16 21
￿
x
￿
11
H-ActD QM H-ActD QM H-ActD QM H-ActD QM H-ActD
91
4
24 25
28 40
P X BW,a*
￿
90
￿
21
￿
52
￿
33
￿
26
￿
14
￿
55
￿
90
￿
94
P X BW,a- ￿0
￿
23
￿
40
￿
9
￿
0
￿
30
￿
65
￿
87
￿
97
M X BW,O''
￿
91
￿
28
￿
17
￿
89
￿
82
￿
43
￿
53
M X BW,o- ￿0
￿
22
￿
15
￿
4
￿
7
￿
27
￿
27
* Cells expressing surface human aL or 0, as detected byindirect immunofluorescence flow cytometry as described in Fig. 2 .
i Determined by karyotyping after staining of metaphase preparations with quinacrine mustard dihydrochloride (QM) or 33258
Hoechst-actinomycin D (H-ActD) as described in Fig. 4 . Forhuman chromosomes where nodata areshown, they werenot detected .
FIGURE 5 .
￿
Identification of humanchromosomes in hybrid cells by Southern hybridization .
5 Ag of high molecular weight DNA from normal human control 1 (lanes 1 and 8) ; normal
human control 2 (lanes2and 9) ; BW5147 (lanes 3 and 10) ;MX BW,a' (lane 4);MXBW,a
(lane 5) ; P X BW,a'(lane 6) ; P XBW,a (lane 7) ;MX BW,ft* (lane 11) ;andM X BW,13- (lane
12) was digested with Eco RI, electrophoresed on a I% agarose gel, and transferred to nylon
membranes. Filters were probed with nick-translated "P-labeled probes specific for human
chromosomes 16 (A)and21 (&), and autoradiographed .
respectively, was further tested by Southern hybridization of hybrid cell DNA
with cloned human DNA segments specific for these two human chromosomes .
A cloned human a, globin gene from chromosome 16 hybridized to an appro-
priate 20 kb band in control human DNA (Fig. 5A, lanes 1 and 2), but not to
mouse BW5147 DNA (Fig . 5A, lane 3) . This probe detected similar-sized
sequences in human aL subunit-positive hybrids derived from the mother's (M
X BW,a+) or patient's (P X BW,a+) cells (Fig . 5A, lanes 4 and 6), but did not
detect human chromosome 16 in hybrids that had lost expression of the human
aL subunit (Fig. 5A, lanes 5and 7) . Note that . the lower intensity of hybridization
with P X BW,a+ DNA relative to the M X BW,a' DNA is consistent with the
relative numbers of cells containing human chromosome 16, as detected byMARLIN ET AL.
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karyotyping (Table I) . A human chromosome 21-specific probe hybridized to
control human DNA and M X BW,#+ DNA (Fig. 5B, lanes 8, 9, and 11), but not
to DNA from either mouse BW5147 cells or M X BW,f-, a hybrid that had lost
human ,B subunit expression (Fig. 5B, lanes 10 and 12). The specific presence of
human chromosomes 16 and 21 in hybrids expressing the human aL and /3
subunits, respectively, and their absence in hybrids that had lost expression
confirm our assignment of the human LFA-1 subunit genes to those chromo-
somes.
Discussion
Hybrid cells expressing interspecies hybrid LFA-1 molecules containing a
human aL subunit complexed with a mouse ,B subunit or a human ,0 subunit
complexed with a mouse aL subunit were isolated here from fusions of normal
human lymphocytes with a mouse T cell line. Based on similarities in subunit
structure, cell distribution, and function, it has previously been proposed (27)
that human and murine LFA-1 are homologs. The observation here that human
and murine LFA-I subunits can coassociate to form interspecies hybrid molecules
that are transported to and expressed on the cell surface demonstrates that the
mouse and human LFA-1 complexes are truly homologs of each other. In
particular, the sites of intersubunit interaction must be closelyconserved between
the twospecies. A similartype of interspecies subunit complex formation between
human HLA and murine 02-microglobulin has previously been reported (28).
A major goal of these studies was to examine whether complementation with
murine subunits could rescue surface expression of human LFA-1 aL or ,0
subunits in mouse X human hybrids formed with LFA-1-deficient patient cells.
T lymphocytes from LFA-1- patients express neither the LFA-1 aL or a subunit
on the cell surface (3). In mouse X human patient cell hybrids, the formation of
interspecies hybrid LFA-1 molecules containing the human aL subunit nonco-
valently associated with the murine fl subunit allowed surface expression of the
human LFA-1 aL subunit to be rescued. We were unable to isolate mouse X
human patient cell hybrids that expressed the human ,Q subunit. In contrast, we
were able to isolate cells expressing the human a subunit associated with the
mouse aL subunit from mouse cells hybridized to cells from the patient's mother.
Intracellular LFA-l aL subunit precursors have previously been detected (3) in
lymphocytes from three different LFA-1-deficient patients. However, since the
aL precursor was not expressed on the cell surface, it was unclear whether such
expression was possible. The results reported here show that the intracellular
aL precursor in patients' cells is normal and is competent for surface expression
in the presence of an appropriate ,#subunit. Furthermore, the inability to isolate
hybrids expressing the human ,Q subunit from patients' cells argues that the 0
subunit is defective. These data support the hypothesis that the primary defect
in LFA-1 deficiency is in the ,0 subunit, and is consistent with the failure of
patients' monocytes and granulocytes to express on their membranes the Mac-1
and p150,95 glycoprotein complexes, which use the same a subunit (3). Forma-
tion of an a,# complex appears to be required for processing and transport to
the cell surface.
Although the presence of a murine # subunit was sufficient to rescue cell864
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surface expression of the patient's LFA-I aL subunit, we do not know at this
time whether surface expression of the related Mac-I aM subunit and p150,95
aX subunits, which associate with the same # subunit, can be similarly rescued .
The hybrids described here did not express human aM or aX subunits (data not
shown); however, these proteins are not normally expressed on cells of T
lymphocyte lineage, such as the mouse BW5147 cell line. The a subunits of
LFA-1, Mac-1, and p150,95 share N-terminal amino acid sequence homology
(29 and our unpublished observations). These proteins may thus have evolved
as a gene family by gene duplication and divergence. It will be interesting to
determine whether the Mac-I and p150,95 a subunit genes are closely linked to
the LFA- I a subunit gene, and whether aM and aX subunit cytoplasmic precur-
sors are present in the inherited deficiency of Mac-1, LFA-1, and p150,95
(referred to herein as LFA-I -deficiency). Fusion of patients' cells wi
cells of myeloid lineage should serve to
We have mapped the genes encoding the human LFA-I al, and # subunits to
chromosomes 16 and 21, respectively. The aL and # subunit genes were thus
assigned to different chromosomes, consistentwith our observation that selection
with mAb specific for only one human subunit did not isolate hybrids expressing
both human subunits. Since our results suggest that the # subunit gene is defective
in LFA-1 deficiency, we infer that the inherited defect itself is on chromosome
21 . It has been suggested (4, 30) that one patient with LFA- I deficiency has an
X-linked defect . However, studies on the patient whose cells were hybridized
here, and on about 20 other patients worldwide show that LFA-I deficiency is
inherited as an autosomal recessive trait (1, 3, 4, 6, 7, 9), consistent with
inheritance on chromosome 21 . Rescue of human aL subunit expression by the
introduction of a functional marine # subunit as reported here suggests that
gene therapy for this disease could be accomplished by the introduction of a
normal, cloned # subunit gene.
Summary
Lymphocyte function associated antigen I (LFA-1) is a leukocyte cell adhesion
protein. We have studied a novel human immunodeficiency disease in which
LFA-I and two other proteins which share the same 0 subunit are lacking from
the surface of leukocytes. The basis of the inherited defect in cell surface
expression of both the a and fl subunits of LFA-I was determined by somatic
cell fusion of patient or normal human cells with an LFA-I' mouse T cell line.
Human LFA-I a and # subunits from normal cells could associate with mouse
LFA- I subunits to form interspecies hybrid aO complexes. Surface expression of
the a but not the 0 subunit of patient cells was rescued by the formation of
interspecies complexes. These findings show that the LFA- I a subunit in genet-
ically deficient cells is competent for surface expression in the presence of an
appropriate # subunit, and suggest that the genetic lesion affects the 0 subunit.
The human LFA-I ce and # subunits were mapped to chromosomes 16 and 21,
respectively. The genetic defect is inferred to be on chromosome 21 .
We thank Dr. Paul ROGNs of Integrated Genetics for the gift of plasmid pPW228C, and
Dr. Jean Amos of the Eunice Kennedy Shriver Center (Framingham, MA) for MentalRetardation for assistance and advice in performing the Southern hybridization experi-
ments. The expert technical assistance of Ms Lois Jeurgens in cytogenetic analyses is
greatly appreciated.
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Note added in proof Suomalainen et al. (31) have also recently mapped a glycoprotein with
characteristics similarto the,B subunit to humanchromosome 21 by karyotypic analysis of interspecies
hybrids. Using similar methods, Tetteroo et al. (32) have reported in abstract form that the human
li subunit can associate with murine Mac-1 and LFA-1 a subunits in interspecies hybrids, and have
also tentatively assigned the human fl subunit to chromosome 21 .
Lymphoid hybrids were obtained from the patient's cells, which contained chromosome 21, but
did not express the human subunit.
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